Sun Pharma launches Sezaby in the U.S. for treatment of neonatal seizures

Sezaby is the first and only FDA-approved product for treating seizures in neonatal patients

FPJ Web DeskUpdated: Wednesday, January 25, 2023, 02:44 PM IST
article-image
Sun Pharma launches Sezaby in the U.S. for treatment of neonatal seizures | Image: Sun Pharma (Representative)

Sun Pharmaceutical Industries Limited today announced the launch of 'Sezaby' (phenobarbital sodium) in the U.S. for the treatment of neonatal seizures, via an exchange filing.

Sezaby is the first and only product approved by the U.S. Food and Drug Administration (USFDA) for the treatment of neonatal seizures in term and preterm infants.

Sezaby is a benzyl alcohol-free and propylene glycol-free formulation of phenobarbital sodium powder for injection.

It was granted orphan drug designation by the US FDA for the treatment of neonatal seizures. “The launch of Sezaby is an exciting addition to our growing portfolio of specialty branded products in the U.S.,” said Abhay Gandhi, CEO North America, Sun Pharma.

“As the first and only FDA-approved product for the treatment of seizures in term and preterm infants, Sezaby has the potential to make a meaningful difference in the lives of patients and their families, and we are proud to be able to provide physicians with this new treatment option.”

(If you have a story in and around Mumbai, you have our ears, be a citizen journalist and send us your story here. )

(To receive our E-paper on WhatsApp daily, please click here.  To receive it on Telegram, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

RECENT STORIES

Adani's relative on SEBI committee raises concerns about conflict of interest

Adani's relative on SEBI committee raises concerns about conflict of interest

TCS named to world’s most admired companies list by Fortune Magazine

TCS named to world’s most admired companies list by Fortune Magazine

Tech Mahindra allots shares worth Rs 4.24 lakh to employees as stock options

Tech Mahindra allots shares worth Rs 4.24 lakh to employees as stock options

Hero MotoCorp launches new campaign for XPulse 200T 4V with Anushka Sharma and Virat Kohli

Hero MotoCorp launches new campaign for XPulse 200T 4V with Anushka Sharma and Virat Kohli

Earnings 2023 LIVE: Indigo net profit jumps at Rs 1,422.61 cr; Reliance Infrastructure net loss...

Earnings 2023 LIVE: Indigo net profit jumps at Rs 1,422.61 cr; Reliance Infrastructure net loss...